SCHEMBL740084

SCHEMBL740084

C1=NOCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31465274 0.63
SCHEMBL3083556 0.54
SCHEMBL6998282 0.45
SCHEMBL76442 0.45
SCHEMBL56190 0.40
SCHEMBL1190870 0.40
SCHEMBL3387 0.38
SCHEMBL20553612 0.31
Fluoride Ion SCHEMBL22554800 0.31 CA4 (0.33)
SCHEMBL6559802 0.27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118834173-A Dichloromethane is used as C1Method for synthesizing 1,4, 2-dioxygen azole compound by source and solvent 汕头大学 2024-10-25 CN claimed
EP-1733715-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolone derivative, a coupling agent and a heterocyclic direct dye OREAL (FR) 2010-01-27 EP claimed
US-7582121-B2 Composition for dyeing keratin fibers, comprising at least one diamino-N,N-dihydropyrazolone derivative, at least one coupler, and at least one heterocyclic direct dye L'OREAL S.A. (FR) 2009-09-01 US claimed
US-20070006398-A1 Composition for dyeing keratin fibers, comprising at least one diamino-N,N-dihydropyrazolone derivative, at least one coupler, and at least one heterocyclic direct dye L'OREAL S.A. (FR) 2007-01-11 US claimed
JP-2006516587-A 2006-07-06 JP claimed
EP-1599204-A2 SELECTIVE MGLU5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT Recordati Ireland Limited (IE) 2005-11-30 EP claimed
CN-1681557-A Methods for treating carbonic anhydrase mediated disorders PHARMACIA CORP (US) 2005-10-12 CN claimed
US-20040215284-A1 Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists RECORDATI S.A. 2004-10-28 US claimed
WO-2004067002-A2 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT RECORDATI IRELAND LIMITED (IE) 2004-08-12 WO claimed
US-20030220376-A1 Methods for treating carbonic anhydrase mediated disorders PHARMACIA CORPORATION 2003-11-27 US claimed
US-5703230-A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same UNIVERSITY OF BRITISH COLUMBIA (CA) 1997-12-30 US claimed
US-20260144252-A1 BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS BAYER AKTIENGESELLSCHAFT (DE) 2026-05-28 US disclosed
US-20260138958-A1 SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES BAYER AG (DE) 2026-05-21 US disclosed
CN-115362157-B Zinc compound, raw material for forming thin film, and method for producing same 株式会社ADEKA 2026-05-15 CN disclosed
US-12617760-B2 [(5-phenyl-1-heteroaryl-1H-triazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants BAYER AKTIENGESELLSCHAFT (DE) 2026-05-05 US disclosed
US-4150223-A ANTIBIOTICS MERCK & CO., INC. (US) 1979-04-17 US disclosed
US-4101431-A EXTREME PRESSURE, ANTIOXIDANT TEXACO INC. (US) 1978-07-18 US disclosed
US-4097479-A FROM ORGANIC NITRILE AND AZIDE ANION, AMINE SOLVENT MILES LABORATORIES, INC. (US) 1978-06-27 US disclosed
US-4051132-A Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench MERCK & CO., INC. (US) 1977-09-27 US disclosed
US-4032521-A ANTIBIOTICS MERCK & CO., INC. (US) 1977-06-28 US disclosed